Generics (UK) v Commission (Judgment): ECFI 8 Sep 2016

ECJ Competition – Agreements, decisions and concerted practices – Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram – Concept of restriction of competition ‘by object’ – Potential competition – Generic medicinal products – Barriers to market entry resulting from the existence of patents – Agreements concluded between a patent holder and a generic undertaking – Error of law – Error of assessment – Rights of defence – Fines

ECLI:EU:T:2016:454, [2016] EUECJ T-469/13


Updated: 22 January 2022; Ref: scu.569058